Metabolites, Volume 14, Issue 11
2024 November - 77 articles
Cover Story: Ovarian cancer (OC) remains one of the most lethal cancers among women due to the lack of accurate and sensitive screening tools, combined with ambiguous symptoms. Such a tool exists for cervical cancer in the Papanicolaou (Pap) test, which greatly reduces this cancer’s mortality rates. Due to the frequency and non-invasive nature of this test, as well as previous evidence of OC cells in Pap tests, this study aims to evaluate the practicality of using such tests as biospecimens for OC screening-related metabolomics. This feasibility study includes the analysis of 29 Pap test samples via mass spectrometry analysis, with the goal of establishing a relative metabolomic profile for healthy women over the age of 50, rendering it the first investigation to utilize residual Pap test samples as biospecimens in a metabolomics workflow. View this paper - Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
- You may sign up for email alerts to receive table of contents of newly released issues.
- PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.